Patents by Inventor Christine Tan

Christine Tan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230340112
    Abstract: Provided are anti-signal regulatory protein ? (SIRP?) antibodies and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of oncological diseases and others.
    Type: Application
    Filed: February 26, 2021
    Publication date: October 26, 2023
    Inventors: Minu K. SRIVASTAVA, Swati JALGAONKAR, Christine TAN, George HUANG, Rena BAHJAT, Xiaodong YANG, Erin L. FlLBERT, Ryan ALVARADO, Sushma KRISHNAN
  • Patent number: 11647925
    Abstract: Techniques to detect a non-alert state of a user may include receiving sensor data from an ear-worn electronic device worn by a user, automatically determining whether to initiate an alertness mode of the ear-worn electronic device based on the sensor data, and determining an alertness state of the user in response to determining to initiate the alertness mode.
    Type: Grant
    Filed: March 19, 2021
    Date of Patent: May 16, 2023
    Assignee: Starkey Laboratories, Inc.
    Inventors: Justin R. Burwinkel, Kyle Olson, Jeffrey Paul Solum, Yoshi Kasahara, Gregory J. Haubrich, Christine Tan
  • Publication number: 20220372154
    Abstract: Provided are anti-tumor necrosis factor receptor 2 (TNFR2) antibodies and related compositions, which may be used in any of a variety of therapeutic or diagnostic methods, including the treatment or diagnosis of oncological diseases, inflammatory and/or autoimmune diseases, and others. In some embodiments, the isolated antibody, or antigen-binding fragment thereof, does not substantially bind to TNFR1, herpesvirus entry mediator (HVEM), CD40, death receptor 6 (DR6), and/or osteoprotegerin (OPG).
    Type: Application
    Filed: September 11, 2020
    Publication date: November 24, 2022
    Inventors: Erin L. FILBERT, Sushma KRISHNAN, Christine TAN, Rena BAHJAT, Xiaodong YANG, Ryan ALVARADO
  • Patent number: 11279762
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Grant
    Filed: July 15, 2019
    Date of Patent: March 22, 2022
    Assignee: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon
  • Publication number: 20210290135
    Abstract: Techniques to detect a non-alert state of a user may include receiving sensor data from an ear-worn electronic device worn by a user, automatically determining whether to initiate an alertness mode of the ear-worn electronic device based on the sensor data, and determining an alertness state of the user in response to determining to initiate the alertness mode.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Inventors: Justin R. Burwinkel, Kyle Olson, Jeffrey Paul Solum, Yoshi Kasahara, Gregory J. Haubrich, Christine Tan
  • Publication number: 20210290102
    Abstract: Techniques to detect a non-alert state of a user may include receiving sensor data from an ear-worn electronic device disposed at least partially in the ear of a user, determining an alertness state of the user based on the sensor data, and providing alert data in response to the alertness state comprising a non-alert state to a user stimulation interface of the ear-worn electronic device or to an external device.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 23, 2021
    Inventors: Justin R. Burwinkel, Kyle Olson, Jeffrey Paul Solum, Yoshi Kasahara, Gregory J. Haubrich, Christine Tan
  • Patent number: 11078283
    Abstract: Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
    Type: Grant
    Filed: January 17, 2019
    Date of Patent: August 3, 2021
    Assignee: Apexigen, Inc.
    Inventors: Pia Björck, Christine Tan, Erin Filbert, Xiaodong Yang
  • Publication number: 20210139589
    Abstract: Provided are anti-VISTA monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of a variety of inflammatory, oncological, and infectious diseases.
    Type: Application
    Filed: June 22, 2018
    Publication date: May 13, 2021
    Inventors: Erin L. Filbert, Christine TAN, Pia BJÖRCK, Xiaodong YANG
  • Publication number: 20200199208
    Abstract: Provided herein are anti-RSPO antibodies, in particular anti-RSPO2 antibodies and/or anti-RSPO3 antibodies, and methods of using the same.
    Type: Application
    Filed: September 30, 2019
    Publication date: June 25, 2020
    Inventors: Elaine Storm, Frederic J. de Sauvage, Jeremy M. Murray, Cameron L. Noland, Yan Wu, Christine Tan, Jo-Anne Hongo, Yongmei Chen
  • Publication number: 20190338034
    Abstract: The invention provides anti-idiotypic antibodies against anti-PD-L1 antibodies and methods of using the same.
    Type: Application
    Filed: July 15, 2019
    Publication date: November 7, 2019
    Applicant: Genentech, Inc.
    Inventors: Jo-Anne Hongo, Angie Yee, Christine Tan, Joyce Lai, Joanne Adamkewicz, John Byon
  • Publication number: 20190218296
    Abstract: Provided are anti-programmed death-ligand 1 (PD-L1) monoclonal antibodies and related compositions, which may be used in any of a variety of therapeutic methods for the treatment of inflammatory and oncological diseases. Specifically, high affinity, humanized anti-PD-L1 antibodies are provided.
    Type: Application
    Filed: January 17, 2019
    Publication date: July 18, 2019
    Inventors: Pia Björck, Christine Tan, Erin Filbert, Xiaodong Yang
  • Patent number: 10196454
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: February 6, 2017
    Date of Patent: February 5, 2019
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Publication number: 20180312579
    Abstract: Provided herein are anti-RSPO antibodies, in particular anti-RSPO2 antibodies and/or anti-RSPO3 antibodies, and methods of using the same.
    Type: Application
    Filed: December 11, 2017
    Publication date: November 1, 2018
    Inventors: Elaine Storm, Frederic J. de Sauvage, Jeremy M. Murray, Cameron L. Noland, Yan Wu, Christine Tan, Jo-Anne Hongo, Yongmei Chen
  • Patent number: 10040047
    Abstract: The present invention relates to a device for isolating and recovering a biomolecule from a test sample. The device includes a support and at least one peelable layer deposited on at least a portion of the support. The peelable layer includes a substrate having a target component immobilized on the substrate. The device is effective for isolating and recovering a biomolecule having affinity to the target component. The present invention also relates to systems and methods of using the device. The present invention also relates to a biomolecule elution strip and related methods.
    Type: Grant
    Filed: June 10, 2015
    Date of Patent: August 7, 2018
    Assignee: CORNELL UNIVERSITY
    Inventors: Harold Craighead, Christine Tan
  • Publication number: 20180000964
    Abstract: The present invention relates to antibodies that bind to receptors expressed on the blood brain barrier and methods of using the same.
    Type: Application
    Filed: June 9, 2017
    Publication date: January 4, 2018
    Applicant: Genentech, Inc.
    Inventors: Christine Tan, Ryan J. Watts, Joy Yu Zuchero, Xiaocheng Chen, Mark S. Dennis
  • Publication number: 20170240645
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: February 6, 2017
    Publication date: August 24, 2017
    Applicant: GENENTECH, INC.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Patent number: 9597411
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: May 6, 2015
    Date of Patent: March 21, 2017
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Publication number: 20150374847
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Application
    Filed: May 6, 2015
    Publication date: December 31, 2015
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark
  • Publication number: 20150360195
    Abstract: The present invention relates to a device for isolating and recovering a biomolecule from a test sample. The device includes a support and at least one peelable layer deposited on at least a portion of the support. The peelable layer includes a substrate having a target component immobilized on the substrate. The device is effective for isolating and recovering a biomolecule having affinity to the target component. The present invention also relates to systems and methods of using the device. The present invention also relates to a biomolecule elution strip and related methods.
    Type: Application
    Filed: June 10, 2015
    Publication date: December 17, 2015
    Applicant: CORNELL UNIVERSITY
    Inventors: Harold CRAIGHEAD, Christine TAN
  • Patent number: 9056910
    Abstract: The invention provides anti-PMEL17 antibodies and immunoconjugates and methods of using the same.
    Type: Grant
    Filed: April 30, 2013
    Date of Patent: June 16, 2015
    Assignee: Genentech, Inc.
    Inventors: Youjun Chen, William Mallet, Paul Polakis, Christine Tan, Jyoti Asundi, Suzanna Clark